Merck & Co., Inc. (MRK)

105.04 +0.32 (+0.31%) USD  |  NYSE  |  Dec 23, 16:00
104.94 -0.10 (-0.10%) Pre-Market: 05:37
More

Merck SG&A Expense (TTM): 10.70B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Biogen, Inc. 2.431B
Regeneron Pharmaceuticals, Inc. 2.717B
Cidara Therapeutics, Inc. 28.09M
Moderna, Inc. 1.061B